The largest randomized controlled trial demonstrates that voriconazole is superior to deoxycholate amphotericin B (D-AMB) as primary treatment for invasive aspergillosis.

• 最大的随机化对照实验证实伏立康唑优于脱氧胆酸二性霉素B(二性霉素B为侵袭性曲菌病的主要治疗措施)。